Finding a way to stop cancerous cells from spreading has been one of science’s Achiles heel, but recently researchers at the University of Southern California and New York University developed a molecule that stops cancer progression.
The molecule halts the interaction between two proteins known to contribute to cancer growth by disguising itself as the surface of a protein and then tricking other proteins into binding with it, stopping the transcription of genetic information that could result in an abnormal gene expression.
The ‘trickster’ is so efficient in targeting protein interactions that it didn’t produce any side effects when tested on mice.
The researchers explained in a news release that targeting protein-protein interactions with drug-like molecules has been a key goal in the field of cancer biology since 2008 – and they have finally filed patent applications for the design.
Several pharmaceutical companies have shown interest in the product. We’ll keep you posted.